Titre : | The rise in treatment admissions for methamphetamine use in Los Angeles County from 2001 through 2005 (2007) |
Titre traduit : | (L'augmentation des admissions en traitement pour usage de méthamphétamine dans le Comté de Los Angeles de 2001 à 2005) |
Auteurs : | CREVECOEUR D. ; RUTKOWXKI B. ; R. A. RAWSON |
Type de document : | Article : Périodique |
Dans : | Journal of Psychoactive Drugs (Vol.37, Suppl.4, 2007) |
Article en page(s) : | 383-392 |
Note générale : |
Journal of Psychoactive Drugs, 2007, 37, (Suppl.4), 383-392 |
Langues: | Anglais |
Discipline : | TRA (Traitement et prise en charge / Treatment and care) |
Mots-clés : |
Thésaurus mots-clés METHAMPHETAMINE ; PRISE EN CHARGE ; ENQUETE ; SEXE ; AGE ; ETHNIE ; EVOLUTION ; TRAITEMENTThésaurus géographique ETATS-UNIS |
Résumé : |
ENGLISH : Drug use trends for people entering county-funded treatment programs from 2001 through 2005 were investigated. The sample was drawn from outpatient counseling, residential treatment, and daycare habititative programs. Findings center on the rising number of admissions to treatment programs for primary methamphetamine (MA) use, with a focus on participant gender, age, and race/ethnicity-Additional participant characteristics, such n referral source, employment, housing, and health status were also briefly explored. This investigation found that the percentage of admissions to treatment programs for primary MA use has substantially increased in Los Angeles County each year from 2001 through 2005. The groups most affected were young people of Asian, Latino, Native American, and White descent. Additionally, it was determined that women were more likely to enter treatment for primary MA use (relative to other drugs) than were males. National implications of these findings, their limitations, and directions for future research are discussed. |
Note de contenu : | fig. ; tabl. |
Domaine : | Drogues illicites / Illicit drugs |
Refs biblio. : | 11 |
Affiliation : |
Integrated Substance Abuse Programs, 1640 S Sepulveda Blvd., Suite 200, Los Angeles CA 90025-7535. Email : desireec@ucla.edu Etats-Unis. United States. |
Numéro Toxibase : | 1302343 |
Centre Emetteur : | 13 OFDT |
Cote : | Abonnement |
Accueil